Yungen Xu
- Organic Chemistry top 2%
- Catalytic C–H Functionalization Methods 12
- Synthesis and biological activity 8
- Biological Psychiatry top 5%
- Tryptophan and brain disorders 8
- Oncology top 5%
- PARP inhibition in cancer therapy 18
- Toxicology top 2%
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 8
- Receptor Mechanisms and Signaling 8
-
- Alzheimer's disease research and treatments 11
-
- Integrated Circuits and Semiconductor Failure Analysis 8
- Co-authors
- Qihua ZhuJian YangLei ShiChongzhao RanDezhong JiYuyan LiGuoqing GongDake Liu
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yungen Xu
145 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 108
- Organic Chemistry 939
- Biological Psychiatry 73
- Oncology 617
- Toxicology 76
- Molecular Biology 1.3k
Countries citing papers authored by Yungen Xu
This map shows the geographic impact of Yungen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yungen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yungen Xu more than expected).
Fields of papers citing papers by Yungen Xu
This network shows the impact of papers produced by Yungen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yungen Xu. The network helps show where Yungen Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yungen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 51 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 39 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 5 | |
| 13 | 2019 | 11 | |
| 14 | 2019 | 45 | |
| 15 | 2019 | 66 | |
| 16 | 2018 | 18 | |
| 17 | 2017 | 35 | |
| 18 | 2016 | 17 | |
| 19 | 2014 | 36 | |
| 20 | 2014 | 52 |
About Yungen Xu
Yungen Xu is a scholar working on Biological Psychiatry, Oncology and Physiology, having authored 147 papers that have together received 2.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (18 papers), Catalytic C–H Functionalization Methods (12 papers), Alzheimer's disease research and treatments (11 papers), Synthesis and biological activity (8 papers), Integrated Circuits and Semiconductor Failure Analysis (8 papers), Histone Deacetylase Inhibitors Research (8 papers), Tryptophan and brain disorders (8 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Organic Chemistry (939 citations), Biological Psychiatry (73 citations) and Oncology (617 citations). Yungen Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qihua Zhu, Jian Yang, Lei Shi, Chongzhao Ran, Dezhong Ji, Yuyan Li, Guoqing Gong, Dake Liu, Jia‐Yu Xue and Yi Zou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.